ProteoWise

About:

ProteoWise offers a technology that provides a unique combination of high information content, high throughput, and low cost.

Website: https://www.proteowise.com/

Top Investors: Propel(X), Connecticut Innovations, Foothill Ventures, Taihill Venture, Newton Fund

Description:

ProteoWise’s technology provides a unique combination of high information content, high throughput, and low cost - all while simplifying the western blot dramatically. This combination is what’s driving the genomic revolution and is needed for proteomics. ProteoWise is founded by a seasoned team of scientists from the Strittmatter Lab at Yale University with a history of innovation.

Total Funding Amount:

$8.95M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Branford, Connecticut, United States

Founded Date:

2018-01-01

Founders:

Mikhail Kostylev, Stephen M. Strittmatter

Number of Employees:

1-10

Last Funding Date:

2021-04-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai